Generic cancer drug candidate put to the test
Knowledge-focused
Completed
This study compares a new capsule form of pomalidomide (Xetrane) with the approved drug Imnovid in healthy male volunteers. The goal is to see if the two versions are absorbed and processed by the body in the same way. Participants receive a single dose of each capsule on separat…
Phase: PHASE1 • Sponsor: Knight Therapeutics (USA) Inc • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC